Canaccord lowered the firm’s price target on Barrick Gold (GOLD) to C$30 from C$33.50 and keeps a Buy rating on the shares. The firm noted the company announcement that it will initiate a ...

By Lily Ford Tony Slattery, star of Channel 4‘s Whose Line Is It Anyway? and a contemporary of Emma Thompson, Hugh Laurie and Stephen Fry, has died. He was 65. In a statement given to the BBC on ...

In a report released today, Aravinda Galappatthige from Canaccord Genuity maintained a Buy rating on Cogeco Communications (CGEAF – Research Report), with a price target of C$77.00. The company ...

Canaccord said Science Group has an impressive and consistent track record of delivering a combination of organic and disciplined inorganic growth with minimal shareholder dilution. "This track ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

Canaccord downgraded Inari Medical (NARI) to Hold from Buy with a price target of $80, up from $74, after Stryker (SYK) entered into a definitive agreement to acquire Inari in cash for $80 per ...

On Friday, Canaccord Genuity analysts increased their price target on Tesla stock (NASDAQ:TSLA) to $404 from the previous target of $298, while reaffirming their Buy rating. The revised target ...

Canaccord Genuity raised its price target on Tesla (TSLA) to $404 per share from $298, citing optimism over the company’s growth, including in its energy business and possible robotics venture.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...